PTPN11 and systemic lupus erythematosus: A SHP2 inhibitor (11a‐1) reversed the symptoms of SLE‐associated organ damage, suggesting that SHP2 is a positive regulator of the development of systemic lupus erythematosus (Wang et al, 2016).